TearOptix Secures Strategic Funding to Transform Presbyopia Treatment and Announces Creation of Scientific Advisory Board

ATHERTON, Calif.–(BUSINESS WIRE)–TearOptix, Inc., a pioneering contact lens company developing advanced solutions for patients with presbyopia, today announced the completion of a strategic corporate financing round led by investors with deep expertise in ophthalmology. Presbyopia is the gradual loss of the eye’s ability to focus on nearby objects, affecting virtually everyone over the age of 40. The company also unveiled its distinguished Scientific Advisory Board, which is composed of globally recognized leaders in vision science, clinical ophthalmology and optical engineering.

“The capital infusion enables us to advance our clinical development and validates our proprietary multifocal lens technology,” said Vartan Ghazarossian, Ph.D., Co-Founder and CEO of TearOptix. “With the strategic guidance of our Scientific Advisory Board, we are moving rapidly to ensure that our products meet the highest standards of safety and clinical performance, establishing a basis for regulatory clearance.”

More than two billion people worldwide are affected by presbyopia, a number expected to grow significantly with global aging. TearOptix’s tear and blink-driven multifocal technology represents a paradigm shift from conventional lenses, delivering unmatched clarity, comfort and seamless vision across all distances.

“Presbyopia remains a major challenge in contact lens-based vision correction,” said Vance Thompson, MD, renowned refractive and cataract surgeon, founder of Vance Thompson Vision, and Co-Founder of TearOptix . “What excites me about TearOptix’s novel approach is its potential to transform everyday vision for millions of people. Our breakthrough technology, our exceptional team and advisors, and the strategic funding together form a strong foundation for delivering our transformative solution to patients worldwide.”

TearOptix’s Scientific Advisory Board unites world-class vision experts in academic research, clinical practice, and optical innovation to steer the company’s product development, clinical programs, and commercialization strategy.

Members of the TearOptix Scientific Advisory Board include:

  • Dr. Ian Cox – President and Founder, IGC Consulting Group; Adjunct Professor, University of Rochester
  • Dr. Jennifer Fogt – Assistant Professor of Optometry, The Ohio State University
  • Dr. Damien Gatinel – Head, Anterior and Refractive Surgery Department, Rothschild Foundation, Paris
  • Dr. Richard Lindstrom – Founder, Minnesota Eye Consultants; Adjunct Clinical Professor Emeritus, University of Minnesota
  • Dr. James Wolffsohn – Professor of Optometry, Aston University, United Kingdom
  • Dr. Aaron Zimmerman – Clinical Professor, College of Optometry, The Ohio State University.

“This investment represents a major step forward in our mission to redefine vision correction for presbyopia,” added Dr. Ghazarossian. “It underscores the confidence our investors have in the science behind our technology and the strength of our team. With continued collaboration from our Scientific Advisory Board, we’re accelerating progress toward delivering innovative optical solutions that improve patients’ quality of life.”

About TearOptix

TearOptix, Inc. is redefining presbyopia correction with its proprietary tear- and blink-responsive contact lens technology, delivering exceptional clarity, comfort, and natural vision at all distances. Headquartered in Silicon Valley, the company merges breakthrough optical engineering with world-class clinical expertise to set a new standard in vision care. TearOptix is committed to transforming the lives of millions affected by age-related vision changes through innovation that bridges science and human experience.

Contacts

Media Contact
Amy Phillips
Amy.phillips@launchlabpartners.com

Social Media

TearOptix Secures Strategic Funding to Transform Presbyopia Treatment and Announces Creation of Scientific Advisory Board

Co-Founder & Co-CEO, Marketing & Brand Experience

Jenna Farr is a healthcare marketing and commercialization executive with more than 18 years of experience across the healthcare industry. Her career began in bariatrics and later expanded into ophthalmology, where she has built more than a decade of specialized experience. Her expertise includes commercialization strategy, brand development, market development, product launch, AI integration, patient and physician marketing, sales team support, digital marketing, and clinical trial recruitment.

Having spent much of her career working inside healthcare companies, Jenna brings an operator’s perspective to the agency side. She understands firsthand what it takes to build markets, launch products, support sales teams, navigate internal priorities, and turn commercialization strategies into programs that can actually be executed.

Today, Jenna is the Co-Founder and Co-CEO of LaunchLab Partners, a healthcare commercialization and marketing firm that works with emerging and established companies at critical stages of growth. She partners closely with executive and commercial teams to clarify positioning, strengthen brands, develop go-to-market strategies, and build integrated programs that drive awareness, adoption, and sustained commercial momentum.

Prior to co-founding LaunchLab Partners, Jenna served as Director of Global Marketing at AcuFocus, where she led global brand and commercialization initiatives and supported the launch of first-of-their-kind ophthalmic technologies. AcuFocus was subsequently acquired by Bausch + Lomb.

In addition to her work in healthcare, Jenna serves as Executive Director of the Orange County Employee Benefits Council, where she supports the organization’s programming, member engagement, and continued growth. She is also a Digital Ambassador for Ophthalmic World Leaders (OWL) and a member of Women in Ophthalmology.

Jenna holds a B.A. in Marketing from San Diego State University and a certificate in Advanced Digital Marketing Growth Strategies from The Wharton School.

Community involvement is also an important part of Jenna’s life. Since 2020, she has been actively involved in Girl Scouts and currently serves as a troop co-leader, while also volunteering in her children’s school and local community. She is a mom of two and is passionate about creating opportunities for young people to build confidence, leadership skills, and meaningful connections.